Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01780545
Title Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Noah Hahn, M.D.
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.